
The Aduhelm Files
All Coverage


In wake of House investigation, 5 burning questions for FDA, Biogen, and Alzheimer’s treatments

‘Rife with irregularities’: Congressional investigation reveals FDA’s approval of Aduhelm marked by secret discussions, breaches of protocol
